Organization
Tokyo Research Unit
1 abstract
Abstract
A low molecular weight baff signallinginhibitor, bik-13, ameliorates b cell activation in vitro and in vivo autoimmune models and consequently suppresses production of igg and cytokinesOrg: Keio University School of Medicine, Tokyo Research Unit, Immunology and Inflammation, Mitsubishi Tanabe Pharma, Yokohama, Japan,